Please login to the form below

Not currently logged in
Email:
Password:

Diurnal

This page shows the latest Diurnal news and features for those working in and with pharma, biotech and healthcare.

Diurnal files adrenal insufficiency drug Alkindi in US

Diurnal files adrenal insufficiency drug Alkindi in US

Could become only treatment for children with the condition. UK specialty drugmaker Diurnal has filed its Alkindi Sprinkle replacement therapy for children with adrenal insufficiency in the US, a group with ... Diurnal said the US marketing application

Latest news

  • Resurgent Diurnal raises £5.4m for twin product filings Resurgent Diurnal raises £5.4m for twin product filings

    Diurnal is recovering from a tricky period after Chronocort failed to meet its primary objective in a pivotal CAH study, sending its share price into freefall last October. ... Diurnal estimates that the EU market for CAH therapies is worth around $300m.

  • Ashfield to establish European MSL network for Diurnal's Infacort Ashfield to establish European MSL network for Diurnal's Infacort

    Ashfield Commercial and Medical Services has been selected by hormone diseases specialist Diurnal to support the launch of its first product, Infacort (hydrocortisone). ... Mark Gibson, director of international business at Ashfield, said: “We are

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

How do companies prepare for reimbursement?
Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
EHR clinical trials
Integrating electronic health records into clinical trials
How organisations are working to realise the research potential of EHRs...
Mike Elliott Gilead
Keeping up the fight against HIV and using the lessons to tackle other threats
Danny Buckland interviews Gilead’s Mike Elliott...

Infographics